RXRX
Price
$7.01
Change
+$0.08 (+1.15%)
Updated
Nov 8, 03:36 PM (EDT)
116 days until earnings call
SANA
Price
$3.00
Change
-$0.10 (-3.23%)
Updated
Nov 8, 04:00 PM (EDT)
125 days until earnings call
Ad is loading...

RXRX vs SANA

Header iconRXRX vs SANA Comparison
Open Charts RXRX vs SANABanner chart's image
Recursion Pharmaceuticals
Price$7.01
Change+$0.08 (+1.15%)
Volume$10.73K
CapitalizationN/A
Sana Biotechnology
Price$3.00
Change-$0.10 (-3.23%)
Volume$136.02K
CapitalizationN/A
View a ticker or compare two or three
RXRX vs SANA Comparison Chart
Loading...
RXRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SANA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
RXRX vs. SANA commentary
Nov 09, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RXRX is a Hold and SANA is a StrongSell.

COMPARISON
Comparison
Nov 09, 2024
Stock price -- (RXRX: $6.93 vs. SANA: $3.10)
Brand notoriety: RXRX and SANA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RXRX: 122% vs. SANA: 200%
Market capitalization -- RXRX: $1.99B vs. SANA: $689.64M
RXRX [@Biotechnology] is valued at $1.99B. SANA’s [@Biotechnology] market capitalization is $689.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.24B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RXRX’s FA Score shows that 0 FA rating(s) are green whileSANA’s FA Score has 1 green FA rating(s).

  • RXRX’s FA Score: 0 green, 5 red.
  • SANA’s FA Score: 1 green, 4 red.
According to our system of comparison, RXRX is a better buy in the long-term than SANA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RXRX’s TA Score shows that 5 TA indicator(s) are bullish while SANA’s TA Score has 4 bullish TA indicator(s).

  • RXRX’s TA Score: 5 bullish, 3 bearish.
  • SANA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than SANA.

Price Growth

RXRX (@Biotechnology) experienced а +9.65% price change this week, while SANA (@Biotechnology) price change was -11.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.66%. For the same industry, the average monthly price growth was +14.64%, and the average quarterly price growth was +11.72%.

Reported Earning Dates

RXRX is expected to report earnings on Mar 04, 2025.

SANA is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (+3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($1.99B) has a higher market cap than SANA($690M). SANA YTD gains are higher at: -24.020 vs. RXRX (-29.716). SANA has higher annual earnings (EBITDA): -229.49M vs. RXRX (-348.35M). RXRX has more cash in the bank: 474M vs. SANA (252M). RXRX has less debt than SANA: RXRX (89.9M) vs SANA (98.6M). RXRX has higher revenues than SANA: RXRX (48.6M) vs SANA (0).
RXRXSANARXRX / SANA
Capitalization1.99B690M288%
EBITDA-348.35M-229.49M152%
Gain YTD-29.716-24.020124%
P/E RatioN/AN/A-
Revenue48.6M0-
Total Cash474M252M188%
Total Debt89.9M98.6M91%
TECHNICAL ANALYSIS
Technical Analysis
RXRXSANA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
RXRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SANA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ILGRX41.710.56
+1.36%
Delaware Ivy Large Cap Growth Fund R6
WELNX9.690.02
+0.21%
William Blair Emerging Mkts Ldrs N
FIDAX19.15N/A
N/A
JHancock Financial Industries A
GSQTX44.53N/A
N/A
Goldman Sachs Small Cap Value Inv
FSVRX11.44N/A
N/A
Clifford Capital Fcs Sm Cp Val Inv

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been loosely correlated with BEAM. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if RXRX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
-0.57%
BEAM - RXRX
62%
Loosely correlated
-1.99%
CRSP - RXRX
57%
Loosely correlated
+2.29%
PRME - RXRX
55%
Loosely correlated
N/A
EXAI - RXRX
55%
Loosely correlated
-0.19%
NTLA - RXRX
53%
Loosely correlated
-0.37%
More